Developing new medicines and vaccines can transform the way we prevent, treat and cure disease. It’s a risky, unpredictable but important journey. That’s why we’re #AlwaysInnovating ifpma.org/alwaysinnovati…

Vaccines can help to protect people at every age and stage of life, prevent global health emergencies and provide vital tools against threats such as antimicrobial resistance. #VaccinesForLife teamvaccines.ifpma.org/future-potenti…

Let's test your knowledge on #mRNA vaccines! Do you know how long it took from the release of the SARS-CoV-2 virus genome sequence to the administration of the first mRNA vaccine designed to combat #COVID19 in a human?

On 16 March 2020, the 1st #mRNA vaccine designed to fight the SARS-CoV-2 virus was administered, marking the start of human clinical trials to test the new vaccine's safety. The shot was administered 66 days after the sequence of the virus’s genome was released.

Pharmaceutical innovation – the core of our industry’s work – relies on pushing the limits of scientific knowledge to advance new medicines and vaccines for the benefit of everyone. That is why we are #AlwaysInnovating to face global health challenges: ifpma.org/initiatives/al…

According to World Health Organization (WHO), AMR is one of the top 10 global public health threats facing humanity. Rising resistance to antibiotics can jeopardize advances in medical treatment. That’s why we need #NewAntibioticsNow. #WAAW2023 ifpma.info/NewAntibiotics…

New treatments are not discovered overnight. Turning an idea into a new medicine or vaccine can take on average 10-15 years. Find out more about the pharmaceutical innovation journey. #AlwaysInnovating ifpma.org/alwaysinnovati…

Vaccines can help to protect people at every age and stage of life, prevent global health emergencies and provide vital tools against threats such as antimicrobial resistance. #VaccinesForLife #WorldImmunizationWeek ifpma.org/insights/how-w…

A ‘staggering’ new study from the Office of Health Economics has delved into the socioeconomic value of adult immunization, with adult vaccination programs returning up to 19x their initial investment, say IFPMA and VaccinesEurope, #VaccinesForLife

Prevention first: Study is a ‘wakeup call’ for health care systems and budget priorities, say IFPMA and VaccinesEurope #VaccinesForLife

New study from Office of Health Economics demonstrates the role vaccines play in supporting our healthcare systems and economies. Read “The Socio-Economic Value of Adult Immunisation Programmes” at ifpma.org/initiatives/va… #VaccinesForLife

Investing in adult vaccination programmes can help protect lives, our healthcare systems and our economies. New study from Office of Health Economics looks at data from across ten countries. Read more at ifpma.org/initiatives/va… #VaccinesForLife

.sibilia quilici opening the event on data driven life course immunisation, which will delve into the important role of data and registries in supporting the implementation of resilient and efficient life-course immunisation programmes.

The report by Office of Health Economics, commissioned by IFPMA, confirms that vaccines save lives, protect public health, & are powerful tools for economic growth. 🎧Hear more from Dr @LotteSteuten, Deputy CEO of OHE, in the One Health Trust podcast "One World, One Health" bit.ly/3WclXQa

Adult vaccination programmes can keep people working, caring for their loved ones, and going about everyday life. Learn more about the economic benefits of investing in these programmes in a recent study by Office of Health Economics at ifpma.org/initiatives/va… #VaccinesForLife

.sibilia quilici at the #ImmuHubs conference: Vaccination is a powerful health prevention tool, contributing to resilient healthcare systems and societies #EUImmunisationStrategy ImmuHubs Vaccine Safety Initiative

Intellectual property boosts the inventiveness that drives progress, helping us find innovative solutions to social, economic, health and environmental challenges and meet our greatest needs and aspirations. #IPMakesItHappen #SDGs #GlobalGoals ifpma.info/3Q43yB3

By supporting healthcare systems and boosting productivity, adult vaccination programmes deliver significant return on investment. Read more on new data from Office of Health Economics ifpma.org/initiatives/va… #VaccinesForLife

New data from Office of Health Economics at ifpma.org/initiatives/va… shows that four adult vaccination programmes can deliver a return on investment similar to childhood immunisation programmes. #VaccinesForLife

Vaccines have saved more lives than any other medical invention in history. Our industry is committed to work with partners to reach underserved communities and further expand vaccine coverage to save millions more lives. #HumanlyPossible ➡️World Health Organization (WHO) asset: trello.com/c/qupCBZk7